Physician Assistant · Miami Beach, FL
NPI
1407033962
Since 2008
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4308 Alton Rd, Suite 980
Miami Beach, FL, 33140
Phone (305) 674-6770
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$98K
358 prescriptions
Company payments, 2025
$42.48
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Doralyn Maya-Azoulay prescribed most often to Medicare patients was Eliquis (Apixaban), with 65 prescriptions and refills. In total Doralyn Maya-Azoulay wrote 358 Medicare prescriptions that cost $98K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Eliquis Apixaban | 65 | 118 | 20 | $68K |
| Metoprolol Succinate Generic | 55 | 161 | 24 | $762 |
| Pindolol Generic | 29 | 80 | Under 11 | $4,108 |
| Sotalol Sotalol Hcl | 22 | 59 | Under 11 | $670 |
| Propafenone Hcl Generic | 19 | 31 | Under 11 | $575 |
| Atenolol Generic | 17 | 27 | Under 11 | $213 |
| Xarelto Rivaroxaban | 16 | 30 | Under 11 | $16K |
| Valsartan Generic | 13 | 38 | Under 11 | $146 |
| Losartan Potassium Generic | 13 | 39 | Under 11 | $122 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 12 | 37 | Under 11 | $381 |
| Fludrocortisone Acetate Generic | 12 | 12 | Under 11 | $235 |
Brand drugs: 95 claims; generic drugs: 263 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Doralyn Maya-Azoulay $42.48 ($42.48 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $42.48.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $42.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.